EMA
approval
· 2015-04-24
First EU treatment for rare sleep-wake disorder
Summary
The European Medicines Agency announces the first EU-approved treatment for a rare sleep-wake disorder, marking a key regulatory milestone for this indication.
Upgrade for the full analysis, importance score, and drug timeline.